Skip to main content

OMEROS CORP

For the period ended Dec 31, 2025. Filed Mar 31, 2026.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Mar 31, 2026

OMER$17.55+3.7%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Signatures

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

OMEROS CORPORATION

/s/ GREGORY A. DEMOPULOS, M.D.

Gregory A. Demopulos, M.D.

President, Chief Executive Officer and Chairman of the Board of Directors

Dated: March 31, 2026

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

SignatureTitleDate
/s/ GREGORY A. DEMOPULOS, M.D.President, Chief Executive Officer and Chairman of the Board of Directors (Principal Executive Officer)March 31, 2026
Gregory A. Demopulos, M.D.
/s/ DAVID J. BORGESVice President, Finance, Chief Accounting Officer and Treasurer (Principal Financial Officer and Principal Accounting Officer)March 31, 2026
David J. Borges
/s/ THOMAS F. BUMOL, PH.D.DirectorMarch 31, 2026
Thomas F. Bumol, Ph.D.
/s/ THOMAS J. CABLEDirectorMarch 31, 2026
Thomas J. Cable
/s/ PETER A. DEMOPULOS, M.D.DirectorMarch 31, 2026
Peter A. Demopulos, M.D.
/s/ ARNOLD C. HANISHDirectorMarch 31, 2026
Arnold C. Hanish
/s/ LEROY E. HOOD, M.D., PH.D.DirectorMarch 31, 2026
Leroy E. Hood, M.D., Ph.D.
/s/ DIANA PERKINSON, M.D.DirectorMarch 31, 2026
Diana Perkinson, M.D.
/s/ RAJIV SHAH, M.D.DirectorMarch 31, 2026
Rajiv Shah, M.D.
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.